Biotech News

Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test

Vivos Therapeutics (VVOS)Vivos TherapeuticsPartnership

Transaction Expected to Increase Stockholders’ Equity; Opens Potential Collaboration Opportunities From New Strategic Alliances Transaction Expected to Increase Stockholders’ Equity; Opens Potential Collaboration Opportunities From New Strategic Alliances

Related news

Vivos Therapeutics

Sleep-Related Breathing Disorder Platform Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders. Its approach combines proprietary oral appliances with diagnostic and clinical services intended to address the anatomical contributors to impaired...

Recent company news

Stock data

Close
0.06 USD
Market cap
9.42M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States